Amy Grammas
Psychiatric/Mental Health · Baltimore, MDNPI 1992172308
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (55.2%), speaking fees and education — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Teva Pharmaceuticals USA, Inc. at 51.5% of the total. Reporting peaked in 2023 at $3,110 and has fallen 87.9% since, to $375 in 2025. Among psychiatric/mental health clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 148 payments — averaging $54.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$4K
- Alkermes, Inc.$1K
- Johnson & Johnson$901
- Vanda Pharmaceuticals Inc.$389
- E.r. Squibb & Sons, L.L.C.$383
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$263
- plus $705 from 7 others
What the payments were for
- Speaking & faculty fees$3,45043%
- Travel & lodging$180%
- Food & beverage$4,47355%
- Education$1622%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 22 | $4,176 |
| Alkermes, Inc. | 25 | $1,287 |
| Johnson & Johnson | 31 | $901 |
| Vanda Pharmaceuticals Inc. | 15 | $389 |
| E.r. Squibb & Sons, L.L.C. | 4 | $383 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 16 | $263 |
| Neurocrine Biosciences, Inc. | 7 | $253 |
| AbbVie | 7 | $116 |
| Otsuka America Pharmaceutical, Inc. | 6 | $96 |
| Noven Therapeutics, LLC | 5 | $81 |
| Indivior Inc. | 4 | $69 |
| Eisai Inc. | 3 | $47 |
| Lundbeck LLC | 3 | $41 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UZEDY$3,450
- LYBALVI$1,768
- ARISTADA$992
- ARISTADA INITIO$248
- Austedo XR$235
- COBENFY$231
- INVEGA SUSTENNA$217
- INVEGA TRINZA$217
- INGREZZA$124
- INVEGA$112
- SPRAVATO$112
How this compares
$8,104 in reported general payments places this provider in the 95th percentile of 1,461 psychiatric/mental health providers in Maryland.
Other psychiatric/mental health in Baltimore
- Olalekan AjayiBaltimore$10K
- Nalo FordBaltimore$8K
- Digna Cespedes-CloudBaltimore$8K
- Gerald ChiaBaltimore$6K
- Chinwe OkudoBaltimore$6K
- Tamar RodneyBaltimore$6K
- Peter IgeBaltimore$5K
- Hara OyedejiOwings Mills$780K
- Ilya RozenbergGlen Burnie$572K
- Michelle WilliamsColumbia$158K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.